-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JxjPtAa/5PT6YB8DkSXlUhAlJAb7OLlAUFu55KnWxdxWhC6jTgm1WdjcsWC44eQb cPgfG2wIUnGMRTCMeJf5sA== 0001419041-09-000004.txt : 20090410 0001419041-09-000004.hdr.sgml : 20090410 20090410150412 ACCESSION NUMBER: 0001419041-09-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090410 DATE AS OF CHANGE: 20090410 EFFECTIVENESS DATE: 20090410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-111231 FILM NUMBER: 09745053 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 D/A 1 primary_doc.xml X0301 D/A LIVE 0001419041 Tocagen Inc 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400 None DE Corporation true 2007 Harry Gruber 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Thomas Darcy 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Douglas Jolly 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Dennis Berman 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Pharmaceuticals Decline to Disclose 06 true 9999999997-09-011360 2008-09-05 false true false 0 9000000 7095750 1904250 Issuer may issue up to 7,200,000 shares of Series B Preferred Stock at $1.25 per share. false 71 0 28750 0 false Tocagen Inc Thomas E. Darcy Thomas E. Darcy Chief Financial Officer 2009-04-10 -----END PRIVACY-ENHANCED MESSAGE-----